Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor - Related Studies - ClinicalTrials.gov

Skip to Main Content

ClinicalTrials.gov

Beta test our new site.

(NLM Technical Bulletin)

Home Search Study Topics Glossary


	Full Text View


	Tabular View


	Study Results


	Related Studies

Investigational Agent AG-013736 In Combinations With Standard Of Care Treatments For Patient's With Advanced Solid Tumor

This study has been completed.

Study NCT00454649 Information provided by Pfizer

First Received on March 29, 2007. Last Updated on March 30, 2012 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Neoplasms

Interventions listed in this trial

Axitinib + Paclitaxel (Cohort 4)
Axitinib + Docetaxel (Cohort 5)
Axitinib + Capecitabine (Cohort 6)
Axitinib + Capecitabine (Cohort 7)

Additional drug interventions recognized in this trial

Angiogenesis Inhibitors
Capecitabine
Carboplatin
Cisplatin
Docetaxel
Fluorouracil
Gemcitabine
Paclitaxel
Pemetrexed

Sponsors listed in this trial

Pfizer

Back to top of Main Content